Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8966 |
High Similarity |
NPD7266 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8284 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD37 |
Approved |
0.8137 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8137 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7941 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7746 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7746 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7705 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6190 |
Approved |
0.763 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7444 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7434 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7434 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7401 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7341 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7288 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.716 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7151 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7076 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7067 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7059 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD6841 |
Approved |
0.6995 |
Remote Similarity |
NPD6842 |
Approved |
0.6995 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD7843 |
Approved |
0.6981 |
Remote Similarity |
NPD5735 |
Approved |
0.6981 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6981 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6974 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7157 |
Approved |
0.6957 |
Remote Similarity |
NPD5588 |
Approved |
0.6957 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6951 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7039 |
Approved |
0.6944 |
Remote Similarity |
NPD7038 |
Approved |
0.6941 |
Remote Similarity |
NPD7411 |
Suspended |
0.694 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD5402 |
Approved |
0.6914 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6902 |
Remote Similarity |
NPD7906 |
Approved |
0.6894 |
Remote Similarity |
NPD4536 |
Approved |
0.6894 |
Remote Similarity |
NPD4538 |
Approved |
0.6894 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD4237 |
Approved |
0.689 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6888 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6888 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6875 |
Remote Similarity |
NPD1933 |
Approved |
0.6875 |
Remote Similarity |
NPD1358 |
Approved |
0.6871 |
Remote Similarity |
NPD5535 |
Approved |
0.6871 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6871 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD3686 |
Approved |
0.6864 |
Remote Similarity |
NPD3687 |
Approved |
0.6852 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6848 |
Remote Similarity |
NPD3750 |
Approved |
0.6848 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6842 |
Remote Similarity |
NPD6386 |
Approved |
0.6842 |
Remote Similarity |
NPD4626 |
Approved |
0.6842 |
Remote Similarity |
NPD6385 |
Approved |
0.6839 |
Remote Similarity |
NPD8651 |
Approved |
0.6839 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6837 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6837 |
Remote Similarity |
NPD7874 |
Approved |
0.6826 |
Remote Similarity |
NPD1511 |
Approved |
0.6826 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6823 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD1608 |
Approved |
0.6818 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD9494 |
Approved |
0.6815 |
Remote Similarity |
NPD5736 |
Approved |
0.6815 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6813 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD2438 |
Suspended |
0.6806 |
Remote Similarity |
NPD6779 |
Approved |
0.6806 |
Remote Similarity |
NPD6780 |
Approved |
0.6806 |
Remote Similarity |
NPD3134 |
Approved |
0.6806 |
Remote Similarity |
NPD6776 |
Approved |
0.6806 |
Remote Similarity |
NPD6781 |
Approved |
0.6806 |
Remote Similarity |
NPD6782 |
Approved |
0.6806 |
Remote Similarity |
NPD6778 |
Approved |
0.6806 |
Remote Similarity |
NPD6777 |
Approved |
0.6805 |
Remote Similarity |
NPD5403 |
Approved |
0.6804 |
Remote Similarity |
NPD7999 |
Approved |
0.6802 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6798 |
Remote Similarity |
NPD27 |
Approved |
0.6798 |
Remote Similarity |
NPD2489 |
Approved |
0.6797 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6795 |
Remote Similarity |
NPD2797 |
Approved |
0.6795 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6788 |
Remote Similarity |
NPD3060 |
Approved |
0.6788 |
Remote Similarity |
NPD7697 |
Approved |
0.6788
|
Remote Similarity |
NPD7698 |
Approved |